10.07.2015 Views

termination of pregnancy in bitches - Jivaonline.net

termination of pregnancy in bitches - Jivaonline.net

termination of pregnancy in bitches - Jivaonline.net

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

GENERAL ARTICLE4. COMBINATION OF PROSTAGLANDINAND DOPAMINE AGONISTSimultaneous adm<strong>in</strong>istration <strong>of</strong> prostagland<strong>in</strong>and dopam<strong>in</strong>e agonist is found to be highly effective.Therapy beg<strong>in</strong>s 28 days after first breed<strong>in</strong>g.Cloprostenol is adm<strong>in</strong>istered subcutaneously onalternative days at a dose rate <strong>of</strong> 1 µg/kg and the drughas to be adm<strong>in</strong>istered three times. Oral cabergol<strong>in</strong>ehas to be given at a dose rate <strong>of</strong> 5µg/kg body weightfor 9 days. This regimen reduces the adverse effects<strong>of</strong> prostagland<strong>in</strong> therapy alone and <strong>in</strong>creases theefficacy <strong>of</strong> prolact<strong>in</strong> antagonists. When the <strong>bitches</strong>were treated for approximately 9 days, 100 percentshowed resorption and there was generally no sideeffects except sangu<strong>in</strong>ous vag<strong>in</strong>al discharge (Oncl<strong>in</strong>et.al, 1995).5. ANTI PROGESTERONE THERAPYAnti-progest<strong>in</strong>s are synthetic steroids thatb<strong>in</strong>d with great aff<strong>in</strong>ity to progesterone receptors,prevent<strong>in</strong>g progesterone from exert<strong>in</strong>g its biologicaleffects. After adm<strong>in</strong>istration <strong>of</strong> the drug peripheralprogesterone concentration rema<strong>in</strong>s unaltered but itsaction is blocked. In dogs, the anti-progest<strong>in</strong>smifepristone and aglepristone have been used forexperimental and cl<strong>in</strong>ical purposes, <strong>in</strong>clud<strong>in</strong>g<strong>pregnancy</strong> <strong>term<strong>in</strong>ation</strong> and management <strong>of</strong>pyometra.a. Mifepristone: -Mifepristone is a progesterone andglucocorticoid antagonist. It is more potent as ananti-progest<strong>in</strong> than as an anti-corticoid. In pregnantwomen, mifepristone is able to <strong>in</strong>terrupt early<strong>pregnancy</strong> <strong>in</strong> 80 percent <strong>of</strong> cases without any majorside effects. To improve its efficacy, mifepristone iscurrently used <strong>in</strong> comb<strong>in</strong>ation with low doses <strong>of</strong>prostagland<strong>in</strong> analogs such as misoprostol. Theefficacy <strong>of</strong> comb<strong>in</strong>ed treatment (mifepristone plusmisoprostol) is 96 percent <strong>in</strong> humans. The drug act asa progesterone receptor antagonist at the level <strong>of</strong> theuterus <strong>in</strong>dependent <strong>of</strong> any additional effects on lutealfunction. Premature cessation <strong>of</strong> luteal function mayhave occurred secondary to the <strong>term<strong>in</strong>ation</strong> <strong>of</strong><strong>pregnancy</strong> or may represent a luteolytic effect <strong>of</strong>treatment <strong>in</strong>dependent <strong>of</strong> <strong>pregnancy</strong> status.Mifepristone has been demonstrated to <strong>in</strong>duce directluteolysis and has an anticorticoid activity.This drug is orally active and has beenshown to be safe and effective <strong>in</strong> term<strong>in</strong>at<strong>in</strong>g<strong>pregnancy</strong> after 30 days <strong>of</strong> gestation. The treatmentprotocol <strong>in</strong>volved oral adm<strong>in</strong>istration <strong>of</strong> drug at therate <strong>of</strong> 2.5 mg/kg twice daily for 4-5 days or untilabortion or resorption occurred (Concanoon et.al,1990). It is a competitive antagonist <strong>of</strong> progesteroneon the receptor level thus hav<strong>in</strong>g most cl<strong>in</strong>ical effects<strong>in</strong> the presence <strong>of</strong> progesterone. Preparation Tab.MTPILL 200mg, MEFIPIL 200mg, UNWANTED200mgB. Aglepristone: - This is a relatively newantiprogesterone drug developed for animal use.Aglepristone can be used any time up to day 45 forsafe effective <strong>term<strong>in</strong>ation</strong> <strong>of</strong> <strong>pregnancy</strong> (Fieni et. al,2001). Aglepristone does not modify plasmaconcentrations <strong>of</strong> progesterone, prostagland<strong>in</strong>s,oxytoc<strong>in</strong> or cortisol with<strong>in</strong> 24 hours after itsadm<strong>in</strong>istration but <strong>in</strong>duces an <strong>in</strong>crease <strong>in</strong>concentrations <strong>of</strong> prolact<strong>in</strong> with<strong>in</strong> 12 hours <strong>in</strong> <strong>bitches</strong>treated <strong>in</strong> mid <strong>pregnancy</strong> (Galac, et. al, 2000). Thiscan expla<strong>in</strong> the mammary gland congestion typicallyobserved after mid <strong>pregnancy</strong> <strong>term<strong>in</strong>ation</strong>.Shorten<strong>in</strong>g <strong>of</strong> the <strong>in</strong>ter-oestrous <strong>in</strong>terval andprolact<strong>in</strong> release seems to prove a direct or <strong>in</strong>directaction <strong>of</strong> aglepristone on hypothalamic-pituitaryaxis. As an abortifacient, aglepristone acts like aprogesterone antagonist, at the uterus level and doesnot have direct and immediate luteolysis properties.Term<strong>in</strong>ation <strong>of</strong> <strong>pregnancy</strong> occurs <strong>in</strong> the presence <strong>of</strong>high plasma progesterone concentrations (Baa<strong>net</strong>.al, 2005)..The early adm<strong>in</strong>istration <strong>of</strong> aglepristone at 0to 25 days after mat<strong>in</strong>g always resulted <strong>in</strong> prevention<strong>of</strong> <strong>pregnancy</strong>. The later adm<strong>in</strong>istration <strong>of</strong>aglepristone at day 26 to 45 after mat<strong>in</strong>g <strong>in</strong>ducedresorbtion or abortion with<strong>in</strong> seven days <strong>in</strong> 96percent <strong>of</strong> cases. There were no untoward sideeffects. The drug can be adm<strong>in</strong>istered at a dosage <strong>of</strong>JIVA Vol. 10 Issue 1 April 201263

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!